Commonwealth Equity Services »

Biomarin Pharmaceutical shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $19k 20k 0.96

More positions owned by Commonwealth Equity Services

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Growth Etf Shs Creation Uni (CGGR)

View all positions for Commonwealth Equity Services

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Lazard Asset Management
BlackRock
Man Group
Capstone Investment Advisors
MacKay Shields
Opti Capital Management
Millennium Management
Verition Fund Management
Oaktree Capital Management
Victory Capital Management
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Jpmorgan Chase & Co

View all funds holding Biomarin Pharmaceutical